All In MedTech

FDA Clearance Tracker · P970038-S046

Access Hybritech free PSA

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 15, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P970038-S046
Device name
Access Hybritech free PSA
Applicant location
Brea, CA
Received
Aug 2, 2024
Decided
May 15, 2025
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P970038

Device type

Device class
Class III

Every decision under product code MTG

FDA's approval statement

As written in FDA's record.

Migration of the Access Hybritech free PSA to the DxI 9000 Access Immunoassay Analyzer.

Source documents

Other decisions for Beckman Coulter, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.